Figure 2From: Treatment patterns in psoriatic arthritis patients newly initiated on oral nonbiologic or biologic disease-modifying antirheumatic drugsBiologic use in oral nonbiologic DMARD patients and in MTX patients.aThis refers to oral nonbiologic DMARD users. bMTX users are a subgroup of the oral nonbiologic DMARD users. cThese categories presented are mutually exclusive. dThese categories presented are mutually exclusive. DMARD, disease-modifying antirheumatic drug; MTX, methotrexate.Back to article page